2022 Q3 Form 10-Q Financial Statement

#000149315222022974 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $4.103M $338.7K $138.5K
YoY Change 1288.46% 66.38% -61.16%
Cost Of Revenue $3.125M $241.1K $95.19K
YoY Change 1015.11% 43.0% -67.57%
Gross Profit $978.1K $97.63K $43.28K
YoY Change 6301.2% 179.01% -31.26%
Gross Profit Margin 23.84% 28.82% 31.26%
Selling, General & Admin $2.619M $1.419M $603.4K
YoY Change 193.13% 22.49% 11.43%
% of Gross Profit 267.79% 1453.3% 1394.13%
Research & Development $113.2K $86.82K
YoY Change -22.65% -13.18%
% of Gross Profit 115.94% 200.6%
Depreciation & Amortization $9.950K $460.00 $480.00
YoY Change 631.62% 142.11% -96.84%
% of Gross Profit 1.02% 0.47% 1.11%
Operating Expenses $2.748M $1.682M $691.1K
YoY Change 182.79% 23.42% 4.69%
Operating Profit -$1.770M -$1.584M -$647.8K
YoY Change 85.06% 19.31% 8.48%
Interest Expense $31.58K $18.00K -$561.0K
YoY Change -108.26% -96.84% -28.56%
% of Operating Profit
Other Income/Expense, Net -$377.2K
YoY Change -19.78%
Pretax Income -$2.147M -$1.602M -$1.209M
YoY Change 50.51% -36.82% -12.37%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.147M -$1.602M -$1.209M
YoY Change 50.51% -36.82% -12.37%
Net Earnings / Revenue -52.34% -473.0% -873.0%
Basic Earnings Per Share -$0.36 -$0.34
Diluted Earnings Per Share -$356.0K -$337.9K -$756.8K
COMMON SHARES
Basic Shares Outstanding 5.251M shares 4.741M shares
Diluted Shares Outstanding 241.3K shares 126.8K shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.186M $2.510M $17.61K
YoY Change 443.02% 838.77% -71.08%
Cash & Equivalents $1.186M $2.510M $17.61K
Short-Term Investments
Other Short-Term Assets $147.8K $529.5K $163.5K
YoY Change -9.58% 666.38% 236.12%
Inventory $6.537M $1.051M $685.9K
Prepaid Expenses $147.8K $529.5K $163.5K
Receivables $2.446M $273.0K $100.8K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.32M $4.364M $967.7K
YoY Change 678.25% 252.76% -12.76%
LONG-TERM ASSETS
Property, Plant & Equipment $486.1K $13.20K $900.00
YoY Change 26903.89% 379.85% -82.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $4.220M $4.750K
YoY Change
Total Long-Term Assets $4.706M $17.95K $900.00
YoY Change 261327.94% 552.58% -92.56%
TOTAL ASSETS
Total Short-Term Assets $10.32M $4.364M $967.7K
Total Long-Term Assets $4.706M $17.95K $900.00
Total Assets $15.02M $4.382M $968.6K
YoY Change 1031.71% 253.42% -13.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.312M $530.6K $1.032M
YoY Change 212.53% -23.79% 91.16%
Accrued Expenses $67.92K $67.92K $204.0K
YoY Change -76.39% -85.94% -66.2%
Deferred Revenue
YoY Change
Short-Term Debt $603.8K $605.0K $3.879M
YoY Change -83.4% -84.71% -17.32%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.988M $1.208M $5.139M
YoY Change -35.94% -76.49% -11.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.988M $1.208M $5.139M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.988M $1.208M $5.139M
YoY Change -35.94% -77.55% -16.22%
SHAREHOLDERS EQUITY
Retained Earnings -$33.35M -$31.20M -$26.97M
YoY Change
Common Stock $8.474K $4.741K $1.597K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.03M $3.174M -$4.170M
YoY Change
Total Liabilities & Shareholders Equity $15.02M $4.382M $968.6K
YoY Change 1031.71% 253.42% -13.62%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$2.147M -$1.602M -$1.209M
YoY Change 50.51% -36.82% -12.37%
Depreciation, Depletion And Amortization $9.950K $460.00 $480.00
YoY Change 631.62% 142.11% -96.84%
Cash From Operating Activities -$2.024M -$979.6K $147.4K
YoY Change 232.81% 518.03% -119.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$13.65K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$10.25M -$13.65K
YoY Change
Cash From Investing Activities -$10.25M -$13.65K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.95M -5.480K -340.7K
YoY Change 1858.38% -101.41% -151.81%
NET CHANGE
Cash From Operating Activities -2.024M -979.6K 147.4K
Cash From Investing Activities -10.25M -13.65K 0.000
Cash From Financing Activities 10.95M -5.480K -340.7K
Net Change In Cash -1.324M -998.7K -193.3K
YoY Change 2600.63% -532.77% 84.13%
FREE CASH FLOW
Cash From Operating Activities -$2.024M -$979.6K $147.4K
Capital Expenditures $0.00 -$13.65K $0.00
Free Cash Flow -$2.024M -$965.9K $147.4K
YoY Change -119.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001648087
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q4 us-gaap Deposit Assets
DepositAssets
usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2022Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q4 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2020Q4 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
usd
CY2021 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2021 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue
usd
CY2021 AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Expired In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredInPeriodTotalIntrinsicValue
usd
CY2021Q4 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
usd
AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue
usd
AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Expired In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredInPeriodTotalIntrinsicValue
usd
CY2022Q2 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41267
dei Entity Registrant Name
EntityRegistrantName
AMERICAN REBEL HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3892903
dei Entity Address Address Line1
EntityAddressAddressLine1
909 18th Avenue South
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37212
dei City Area Code
CityAreaCode
(833)
dei Local Phone Number
LocalPhoneNumber
267-3235
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
AREB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5250632 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2509975 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17607 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
272995 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
100746 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
529492 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
163492 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
826494 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
685854 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
224894 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
4363850 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
967699 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13196 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
900 usd
CY2022Q2 us-gaap Deposit Assets
DepositAssets
4750 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4750 usd
CY2022Q2 us-gaap Assets
Assets
4381796 usd
CY2021Q4 us-gaap Assets
Assets
968599 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
530611 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1032264 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
67919 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
203972 usd
CY2021Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
10373 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
605037 usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3879428 usd
CY2022Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
4385 usd
CY2021Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
12939 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1207952 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5138976 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1207952 usd
CY2021Q4 us-gaap Liabilities
Liabilities
5138976 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4741321 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4741321 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1597370 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1597370 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
4741 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1597 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34368914 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22797306 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31199986 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26969657 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3173844 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4170377 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4381796 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
968599 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
338706 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203577 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
241078 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
168586 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
97628 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
34991 usd
CY2022Q2 us-gaap Legal Fees
LegalFees
246407 usd
CY2021Q2 us-gaap Legal Fees
LegalFees
971213 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
113190 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
146327 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
149249 usd
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
57774 usd
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1172418 usd
CY2021Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
187148 usd
CY2022Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
455 usd
CY2021Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
185 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1681719 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1362647 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1584091 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1327656 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
18001 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
569891 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-638148 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1602092 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2535695 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1602092 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2535695 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.15
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4741000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1179138 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
492786 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
552867 usd
us-gaap Cost Of Revenue
CostOfRevenue
337797 usd
us-gaap Cost Of Revenue
CostOfRevenue
436731 usd
us-gaap Gross Profit
GrossProfit
154989 usd
us-gaap Gross Profit
GrossProfit
116136 usd
us-gaap Legal Fees
LegalFees
709396 usd
us-gaap Legal Fees
LegalFees
1117219 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
146463 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233060 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
230219 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
104114 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1610723 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
366964 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1355 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1798 usd
us-gaap Operating Expenses
OperatingExpenses
2698156 usd
us-gaap Operating Expenses
OperatingExpenses
1823155 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2543167 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1707019 usd
us-gaap Interest Expense
InterestExpense
310406 usd
us-gaap Interest Expense
InterestExpense
1118143 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1376756 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-638148 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4230329 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3463310 usd
us-gaap Net Income Loss
NetIncomeLoss
-4230329 usd
us-gaap Net Income Loss
NetIncomeLoss
-3463310 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.28
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3955000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1055975 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5012437 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
150000 usd
AREB Stock Issued During Period Of Common Stock Issued To Pay Expense
StockIssuedDuringPeriodOfCommonStockIssuedToPayExpense
105466 usd
us-gaap Net Income Loss
NetIncomeLoss
-3463310 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5684586 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4170377 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4170377 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9038456 usd
AREB Stock Issued During Period Of Common Stock Issued To Pay Expense
StockIssuedDuringPeriodOfCommonStockIssuedToPayExpense
969535 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1566559 usd
us-gaap Net Income Loss
NetIncomeLoss
-4230329 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3173844 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3173844 usd
us-gaap Net Income Loss
NetIncomeLoss
-4230329 usd
us-gaap Net Income Loss
NetIncomeLoss
-3463310 usd
us-gaap Depreciation
Depreciation
1355 usd
us-gaap Depreciation
Depreciation
1798 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
969535 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
2096533 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1000457 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
495789 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
172307 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33668 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
469295 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13610 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
140639 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80166 usd
AREB Increase Decrease In Inventory Deposits
IncreaseDecreaseInInventoryDeposits
224894 usd
AREB Increase Decrease In Inventory Deposits
IncreaseDecreaseInInventoryDeposits
-141164 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-637706 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
400891 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3903823 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-387243 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13651 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13651 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-81506 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
23725 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9038456 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
645005 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
60000 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1280000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2607108 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1362427 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6409842 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
586303 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2492368 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
199060 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17607 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68307 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2509975 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
267367 usd
us-gaap Interest Paid Net
InterestPaidNet
206607 usd
us-gaap Interest Paid Net
InterestPaidNet
148226 usd
AREB Debt Repayment Through Issuance Of Common Stock
DebtRepaymentThroughIssuanceOfCommonStock
1950224 usd
AREB Debt Repayment Through Issuance Of Common Stock
DebtRepaymentThroughIssuanceOfCommonStock
1488924 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-15
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
us-gaap Fiscal Period
FiscalPeriod
<p id="xdx_84A_eus-gaap--FiscalPeriod_zlmHzFtEEFCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Year end</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/> </p>
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
900 usd
us-gaap Depreciation
Depreciation
1355 usd
us-gaap Depreciation
Depreciation
1798 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
149249 usd
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
57774 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
230219 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
104114 usd
us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
less than a 50% likelihood
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zDEqRmlPn8oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Net Income Loss
NetIncomeLoss
-4230329 usd
us-gaap Net Income Loss
NetIncomeLoss
-3463310 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31199986 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26969657 usd
CY2022Q2 AREB Working Capital Deficit
WorkingCapitalDeficit
3155898 usd
CY2021Q4 AREB Working Capital Deficit
WorkingCapitalDeficit
-4171277 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
826494 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
685854 usd
CY2022Q2 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
224894 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1051388 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
685854 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
323798 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
310147 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
310602 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
309247 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13196 usd
CY2016Q4 us-gaap Loans Payable
LoansPayable
277886 usd
CY2022Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
4385 usd
CY2021Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
12939 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On February 7, 2022, the Company effectuated a reverse split of its issued and outstanding shares of common stock at a ratio of 1-for-80. The share numbers and pricing information in this report are adjusted to reflect the reverse stock split
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4741321 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4741321 shares
CY2022Q2 us-gaap Secured Debt
SecuredDebt
605037 usd
CY2021Q4 us-gaap Secured Debt
SecuredDebt
4952326 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
31199986 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
26969657 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
43688 shares
CY2020Q4 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
20.80
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y5M23D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
662713 shares
CY2021 AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
8.00
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6466694 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5663628 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6466694 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5663628 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6466694 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5663628 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6466694 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5663628 usd
us-gaap Valuation Allowance Deferred Tax Asset Explanation Of Change
ValuationAllowanceDeferredTaxAssetExplanationOfChange
As a result, management determined it was more likely than not deferred tax assets will not be realized as of June 30, 2022, and December 31, 2021, and recognized 100% valuation allowance for each period
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.000 pure
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.210 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1597370 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1597370 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4365446 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
701776 shares
CY2021 AREB Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
P2Y11M12D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
4625 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
701776 shares
CY2021Q4 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
8.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y11M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
2909639 shares
AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
5.1875
AREB Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
P5Y
AREB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Debt Conversion
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInDebtConversion
377484 shares
AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Debt Conversion Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInDebtConversionWeightedAverageExercisePrice
5.1875
AREB Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted In Debt Conversion Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInDebtConversionWeightedAverageRemainingContractualTerm2
P5Y
AREB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Prefunded
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedPrefunded
377484 shares
AREB Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants Prefunded Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsPrefundedWeightedAverageExercisePrice
0.01
AREB Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Prefunded Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedPrefundedWeightedAverageRemainingContractualTerm2
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
938 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4365446 shares
CY2022Q2 AREB Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
5.05
AREB Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
P4Y2M19D
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
169096 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
76628 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
77681 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
78755 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
19689 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
421848 usd
us-gaap Payments For Rent
PaymentsForRent
112000 usd
us-gaap Payments For Rent
PaymentsForRent
100000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd

Files In Submission

Name View Source Status
0001493152-22-022974-index-headers.html Edgar Link pending
0001493152-22-022974-index.html Edgar Link pending
0001493152-22-022974.txt Edgar Link pending
0001493152-22-022974-xbrl.zip Edgar Link pending
areb-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
areb-20220630_cal.xml Edgar Link unprocessable
areb-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
areb-20220630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
areb-20220630_lab.xml Edgar Link unprocessable